BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20877)

  • 1. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST; Harrison R; Quayle E; Pagel J; Monti J
    Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Hydroxytryptamine binding to synaptic membranes from rat brain.
    Fillion G; Fillion MP; Spirakis C; Bahers JM; Jacob J
    Life Sci; 1976 Jan; 18(1):65-74. PubMed ID: 2829
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 5. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM; Rousselle JC; Fillion MP; Beaudoin DM; Goiny MR; Deniau JM; Jacob JJ
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract]   [Full Text] [Related]  

  • 6. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

  • 7. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
    Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
    Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.
    Sitaram BR; Lockett L; Talomsin R; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 May; 36(9):1509-12. PubMed ID: 3472526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
    Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
    Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.
    Yanai K; Ido T; Ishiwata K; Hatazawa J; Takahashi T; Iwata R; Matsuzawa T
    Eur J Nucl Med; 1986; 12(3):141-6. PubMed ID: 3489620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates.
    Barker SA; Monti JA; Christian ST
    Biochem Pharmacol; 1980 Apr; 29(7):1049-57. PubMed ID: 6770869
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
    Morinan A; Collier JG
    Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
    Ruffing D; Kovacic B; Demetriou S; Domino EF
    Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens.
    Whipple MR; Reinecke MG; Gage FH
    J Neurochem; 1983 Apr; 40(4):1185-8. PubMed ID: 6131933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G; Fillion MP; Rousselle JC; Beaudoin D; Goiny M; Jacob J
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):979-81. PubMed ID: 405135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain.
    Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
    Biochem Pharmacol; 1984 May; 33(9):1395-400. PubMed ID: 6587850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of LSD and 5-methoxy-N,N-dimethyltryptamine on the high affinity uptake of [3H]-serotonin by isolated rat brain synaptosomes].
    Uebelhack R; Franke L; Seidel K
    Acta Biol Med Ger; 1978; 37(10):1611-4. PubMed ID: 752213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver.
    Wang Lu LJ; Domino E
    Biochem Pharmacol; 1976 Jul; 25(13):1521-7. PubMed ID: 1066131
    [No Abstract]   [Full Text] [Related]  

  • 20. Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats.
    Beaton JM; Morris PE
    Mech Ageing Dev; 1984 Jun; 25(3):343-7. PubMed ID: 6588281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.